Hillman Capital Management 13F, Q4 2025
Hillman Capital · quarter ending 31 December 2025 · filed 17 February 2026 · SEC CIK 1314620
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2025
The 25 largest of 56 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2025 filing.
| Company | Ticker | Value | % of book | vs Q3 2025 |
|---|---|---|---|---|
| WARNER BROS DISCOVERY INC | WBD | $6.18M | 3.9% | -35% shares |
| ASML HOLDING N V | $5.89M | 3.7% | -19% shares | |
| LAUDER ESTEE COS INC | EL | $5.74M | 3.6% | -23% shares |
| CVS HEALTH CORP | CVS | $5.69M | 3.6% | -13% shares |
| GSK PLC | GSK | $5.61M | 3.5% | -19% shares |
| BOEING CO | BA | $5.52M | 3.5% | -11% shares |
| BIOGEN INC | BIIB | $5.37M | 3.4% | -20% shares |
| DUPONT DE NEMOURS INC | DWDPEUR | $5.36M | 3.4% | +87% shares |
| ANHEUSER BUSCH INBEV SA/NV | BUD | $5.29M | 3.3% | -9% shares |
| INTERNATIONAL FLAVORS&FRAGRA | IFF | $5.12M | 3.2% | -4% shares |
| MICROSOFT CORP | MSFT | $5.12M | 3.2% | -8% shares |
| SPDR S&P 500 ETF TR | SPY | $4.55M | 2.9% | new |
| PFIZER INC | PFE | $4.37M | 2.8% | -19% shares |
| NIKE INC | NKE | $4.34M | 2.7% | -8% shares |
| CARMAX INC | KMX | $4.29M | 2.7% | +21% shares |
| KRAFT HEINZ CO | KHC | $4.29M | 2.7% | -16% shares |
| ZIMMER BIOMET HOLDINGS INC | ZBH | $4.13M | 2.6% | -13% shares |
| BAXTER INTL INC | BAX | $4.04M | 2.5% | -11% shares |
| THE CAMPBELLS COMPANY | CPB | $3.92M | 2.5% | -19% shares |
| BROWN FORMAN CORP | BF/B | $3.86M | 2.4% | -21% shares |
| BRISTOL-MYERS SQUIBB CO | BMY | $2.91M | 1.8% | -22% shares |
| TAIWAN SEMICONDUCTOR MFG LTD | TSM | $2.87M | 1.8% | -16% shares |
| US BANCORP DEL | USB | $2.84M | 1.8% | -14% shares |
| AKAMAI TECHNOLOGIES INC | AKAM | $2.79M | 1.8% | +656% shares |
| DISNEY WALT CO | DIS | $2.79M | 1.8% | -11% shares |
What changed since Q3 2025
Against the Q3 2025 filing, Hillman Capital Management opened 3 new positions, added to 7, trimmed 41, left 5 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
- SPY$4.55M
- SPYM$349.9K
- BWX$140.6K
Exited
Nothing from the previous filing was sold outright.
Added to
Other quarters
Source: SEC Form 13F-HR, accession 0001398344-26-003212, filed by Hillman Capital Management, Inc.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.